Stock listing

RO Stock Price, News, Filings & Events — Roche Holding Ltd

Selected listing: RO · SIX · CHF · CH

This page tracks Roche Holding Ltd's RO:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RO:SIX. RO:SIX is the stock-level entry point for investors researching Roche Holding Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Roche Holding Ltd is a prominent public company based in Switzerland, with a market capitalization of approximately 341.1 billion Swiss francs. The company is known for its contributions to the healthcare sector, focusing on pharmaceuticals and diagnostics. Roche is committed to innovation and improving patient outcomes through its extensive research and development efforts.

RO:SIXCHFCHUpdated August 29, 2026
Roche Holding Ltd logo
Ticker
RO:SIX
Asset type
Stock
Market cap
$361.43B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
SIX
Currency
CHF

Roche Holding Ltd RO:SIX stock context

This page tracks Roche Holding Ltd's RO:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RO:SIX. RO:SIX is the stock-level entry point for investors researching Roche Holding Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Roche Holding Ltd is a prominent public company based in Switzerland, with a market capitalization of approximately 341.1 billion Swiss francs. The company is known for its contributions to the healthcare sector, focusing on pharmaceuticals and diagnostics. Roche is committed to innovation and improving patient outcomes through its extensive research and development efforts.

Latest news from Roche Holding Ltd

All Roche Holding Ltd news →

Roche Holding Ltd earnings calls

Research Roche Holding Ltd

Alternate listings